Pictet Asset Management’s Disc Medicine IRON Stock Holding History

Pictet Asset Management’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.2M	Sell	385,375 -1,630	-0.4%	-$112K	0.03%	450
2026 Q1	$24.7M	Sell	387,005 -7,369	-2%	-$511K	0.03%	453
2025 Q4	$31.3M	Buy	394,374 +390,811	+10,969%	+$33M	0.03%	416
2025 Q3	$235K	Buy	+3,563	New	+$212K	﹤0.01%	1791
2025 Q2	–	Sell	-130,386	Closed	-$6.47M	–	2030
2025 Q1	$6.47M	Buy	130,386 +904	+0.7%	+$50.3K	0.01%	754
2024 Q4	$8.21M	Sell	129,482 -28,066	-18%	-$1.62M	0.01%	716
2024 Q3	$7.74M	Sell	157,548 -59,153	-27%	-$2.78M	0.01%	720
2024 Q2	$9.77M	Sell	216,701 -15,096	-7%	-$513K	0.01%	632
2024 Q1	$14.4M	Buy	231,797 +36,706	+19%	+$2.38M	0.02%	573
2023 Q4	$11.3M	Buy	+195,091	New	+$9.99M	0.01%	617

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pictet Asset Management's IRON Position: Q2 2026 in Review

Pictet Asset Management reduced its Disc Medicine (IRON) stake by 0.42% in Q2 2026, selling an estimated $112K and leaving 385,375 shares worth $28.2M. The position accounts for 0.03% of the portfolio, ranked #450.

Pictet Asset Management first reported a position in IRON in Q4 2023 and has held it in 10 quarters since. The position peaked at $31.3M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Pictet Asset Management held 385,375 shares of Disc Medicine worth $28.2M as of Q2 2026.
Pictet Asset Management sold 1,630 Disc Medicine shares in Q2 2026, an estimated $112K.
Disc Medicine made up 0.03% of Pictet Asset Management's portfolio in Q2 2026, its #450 holding.
Pictet Asset Management first reported a position in Disc Medicine in Q4 2023 and has held it in 10 quarters since.
Pictet Asset Management's Disc Medicine position peaked at $31.3M in Q4 2025.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.